NCT04983901 2024-11-04
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
6 trialsNCT05784844 2024-09-19
Antimicrobial Revision in Persistent Febrile Neutropenia
Wake Forest University Health Sciences
Phase 4 Withdrawn
NCT06293677 2024-07-11
DAR-ARC
Centre Hospitalier Universitaire Vaudois
Phase 4 Recruiting
NCT05393505 2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4 Unknown
NCT05392634 2022-05-31
MACS
N.N. Petrov National Medical Research Center of Oncology
Phase 3 Unknown
NCT03485950 2022-03-15
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
M.D. Anderson Cancer Center
Phase 2 Completed